FIRST TRUST ADVISORS LP - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST TRUST ADVISORS LP ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q2 2017$317,000
+2.6%
128,338
-5.8%
0.00%0.0%
Q1 2017$309,000
-21.4%
136,247
-26.6%
0.00%0.0%
Q4 2016$393,000
+30.6%
185,610
+106.3%
0.00%0.0%
Q3 2016$301,000
-92.6%
89,982
-92.2%
0.00%
-90.9%
Q4 2015$4,071,000
-96.2%
1,150,124
-94.6%
0.01%
-96.5%
Q3 2015$107,655,000
-4.5%
21,402,567
+22.0%
0.31%
+6.5%
Q2 2015$112,762,000
+13.6%
17,536,793
+24.3%
0.29%
+0.3%
Q1 2015$99,283,000
+48.2%
14,112,748
+62.4%
0.29%
+29.2%
Q4 2014$67,012,000
+715.4%
8,691,598
+690.1%
0.23%
+606.2%
Q3 2014$8,218,000
-27.8%
1,100,109
-6.4%
0.03%
-31.9%
Q2 2014$11,379,000
+33.3%
1,175,524
+14.4%
0.05%
+23.7%
Q1 2014$8,538,000
-18.6%
1,027,417
-17.4%
0.04%
-25.5%
Q4 2013$10,494,000
+11.7%
1,243,372
+5.5%
0.05%0.0%
Q3 2013$9,394,000
+6.8%
1,178,712
+3.5%
0.05%
-10.5%
Q2 2013$8,795,0001,139,2240.06%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2013
NameSharesValueWeighting ↓
SMH CAPITAL ADVISORS INC 81,713$176,0000.39%
BRANDES INVESTMENT PARTNERS, LP 5,465,156$11,805,0000.30%
Crestline Management, LP 875,000$1,890,0000.30%
West Family Investments, Inc. 539,450$1,165,0000.29%
WEBER ALAN W 200,000$432,000,0000.19%
Zebra Capital Management LLC 73,910$160,0000.18%
RBF Capital, LLC 569,323$1,230,0000.14%
Leap Investments LP 69,496$150,0000.08%
Connor, Clark & Lunn Investment Management Ltd. 4,387,038$9,476,0000.06%
CHICAGO EQUITY PARTNERS LLC 519,315$1,122,0000.05%
View complete list of PDL BIOPHARMA INC shareholders